Sign Out
Hypersensitivity to alfuzosin or any component of the formulation.
Concurrent use with potent CYP3A4 inhibitors (eg. ketoconazole, itraconazole, ritonavir) or other alpha1-blocking agents.
Moderate or severe hepatic insufficiency (Child-Pugh class B or C).
Severe kidney failure (creatinine clearance <30 ml/min).
Postural hypotension.
Continue with Google